Company profile
Orthometrix, Inc.
OTC: OMRX · Healthcare · Medical - Specialties
#826 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 41
v0.1 · 5/100 weight · pillars only
↑ return on assets, net margin · ↓ market scale, Altman-Z
Methodology →Revenue TTM
$1.5M
Rev growth YoY (TTM)
-29.6%
Net income (FY)
$416.1k
Employees
7
as of 2026-08-30
Market cap
$4.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.5M$1.5M2014
Net income$416.1k$416.1k2014
Operating income$263.4k$263.4k2014
Total assets$809.8k$809.8k2014
Liabilities$3.3M$3.3M2014
Equity-$2.5M-$2.5M2014
Revenue trend
FY2003 – FY2014 · USD
FY03
FY04
FY05
FY06
FY07
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Orthometrix, Inc.’s revenue?
Orthometrix, Inc. booked $1.5M in FY2014 revenue, growing 43% year over year — faster than most Healthcare companies we track, at a 27.2% net margin.
Peers · Healthcare
BG Medicine, Inc.——Acura Pharmaceuticals, Inc.——Celldex Therapeutics, Inc.58CMolecule Holdings Inc.——New Leaf Ventures Inc——St. Joseph, Inc.67BNeighbors
Collier →Key facts
CEOReynald G. Bonmati
SectorHealthcare
IndustryMedical - Specialties
HeadquartersNaples, FL
ExchangeOTC: OMRX
Employees7
IPO date1995-08-02
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.